Ignite Creation Date:
2024-05-06 @ 12:39 PM
Last Modification Date:
2024-10-26 @ 1:02 PM
Study NCT ID:
NCT03814226
Status:
UNKNOWN
Last Update Posted:
2019-01-23
First Post:
2019-01-15
Brief Title:
PACAP-38 Infusion in Patients With Cluster Headache
Sponsor:
Danish Headache Center
Organization:
Danish Headache Center
Study Overview
Official Title:
The Effect of PACAP-38 Infusion in Inducing Headache in Patients With Cluster Headache
Status:
UNKNOWN
Status Verified Date:
2019-01
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A randomized double-blinded two-way crossover study investigating the headache inducing capabilities of PACAP-38 in patients with cluster headache Forty-five patients 15 episodic patients in cluster 15 episodic patients in remission and 15 chronic cluster headache patients are expected to participate Each patients will on two separate study days in a randomized way receive an infusion of PACAP-38 and VIP over 20 minutes followed by an observation period of 70 minutes Blood samples for investigation of VIP PACAP38 CGRP NSE Histamine and Tryptase will be drawn at fixed time-points during experiment
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None